 | • レポートコード：QYR2104Z3987 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、結核菌のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（リアルタイム検査、核酸増幅検査、結核用皮膚検査、その他）、用途別市場規模（病院、専門クリニック、診断研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・結核菌の市場動向 ・企業の競争状況、市場シェア ・結核菌の種類別市場規模（リアルタイム検査、核酸増幅検査、結核用皮膚検査、その他） ・結核菌の用途別市場規模（病院、専門クリニック、診断研究所） ・結核菌の北米市場規模2016-2027（アメリカ、カナダ） ・結核菌のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・結核菌のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・結核菌の中南米市場規模2016-2027（メキシコ、ブラジル） ・結核菌の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Lupin、Macleods Pharmaceuticals、Otsuka Pharmaceutical、Johnson & Johnson、Pfizer、Novartis、Abbott、AstraZeneca、Bayer、Merck、Sanofi、Thermo Fisher Scientific、Danaher、Roche、Novartis） ・結論 |
Market Analysis and Insights: Global Mycobacterium Tuberculosis Market
The global Mycobacterium Tuberculosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mycobacterium Tuberculosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mycobacterium Tuberculosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mycobacterium Tuberculosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mycobacterium Tuberculosis market.
Global Mycobacterium Tuberculosis Scope and Market Size
Mycobacterium Tuberculosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mycobacterium Tuberculosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Real-time Inspection
Nucleic Acid Amplification Test
Skin Test for Tuberculosis
Other
Segment by Application
Hospital
Specialist Clinic
Diagnostic Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Johnson & Johnson
Pfizer
Thermo Fisher Scientific
Danaher
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mycobacterium Tuberculosis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Real-time Inspection
1.2.3 Nucleic Acid Amplification Test
1.2.4 Skin Test for Tuberculosis
1.2.5 Other
1.3 Market by Application
1.3.1 Global Mycobacterium Tuberculosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Diagnostic Laboratory
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mycobacterium Tuberculosis Market Perspective (2016-2027)
2.2 Mycobacterium Tuberculosis Growth Trends by Regions
2.2.1 Mycobacterium Tuberculosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Mycobacterium Tuberculosis Historic Market Share by Regions (2016-2021)
2.2.3 Mycobacterium Tuberculosis Forecasted Market Size by Regions (2022-2027)
2.3 Mycobacterium Tuberculosis Industry Dynamic
2.3.1 Mycobacterium Tuberculosis Market Trends
2.3.2 Mycobacterium Tuberculosis Market Drivers
2.3.3 Mycobacterium Tuberculosis Market Challenges
2.3.4 Mycobacterium Tuberculosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mycobacterium Tuberculosis Players by Revenue
3.1.1 Global Top Mycobacterium Tuberculosis Players by Revenue (2016-2021)
3.1.2 Global Mycobacterium Tuberculosis Revenue Market Share by Players (2016-2021)
3.2 Global Mycobacterium Tuberculosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mycobacterium Tuberculosis Revenue
3.4 Global Mycobacterium Tuberculosis Market Concentration Ratio
3.4.1 Global Mycobacterium Tuberculosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mycobacterium Tuberculosis Revenue in 2020
3.5 Mycobacterium Tuberculosis Key Players Head office and Area Served
3.6 Key Players Mycobacterium Tuberculosis Product Solution and Service
3.7 Date of Enter into Mycobacterium Tuberculosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mycobacterium Tuberculosis Breakdown Data by Type
4.1 Global Mycobacterium Tuberculosis Historic Market Size by Type (2016-2021)
4.2 Global Mycobacterium Tuberculosis Forecasted Market Size by Type (2022-2027)
5 Mycobacterium Tuberculosis Breakdown Data by Application
5.1 Global Mycobacterium Tuberculosis Historic Market Size by Application (2016-2021)
5.2 Global Mycobacterium Tuberculosis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Mycobacterium Tuberculosis Market Size (2016-2027)
6.2 North America Mycobacterium Tuberculosis Market Size by Type
6.2.1 North America Mycobacterium Tuberculosis Market Size by Type (2016-2021)
6.2.2 North America Mycobacterium Tuberculosis Market Size by Type (2022-2027)
6.2.3 North America Mycobacterium Tuberculosis Market Size by Type (2016-2027)
6.3 North America Mycobacterium Tuberculosis Market Size by Application
6.3.1 North America Mycobacterium Tuberculosis Market Size by Application (2016-2021)
6.3.2 North America Mycobacterium Tuberculosis Market Size by Application (2022-2027)
6.3.3 North America Mycobacterium Tuberculosis Market Size by Application (2016-2027)
6.4 North America Mycobacterium Tuberculosis Market Size by Country
6.4.1 North America Mycobacterium Tuberculosis Market Size by Country (2016-2021)
6.4.2 North America Mycobacterium Tuberculosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Mycobacterium Tuberculosis Market Size (2016-2027)
7.2 Europe Mycobacterium Tuberculosis Market Size by Type
7.2.1 Europe Mycobacterium Tuberculosis Market Size by Type (2016-2021)
7.2.2 Europe Mycobacterium Tuberculosis Market Size by Type (2022-2027)
7.2.3 Europe Mycobacterium Tuberculosis Market Size by Type (2016-2027)
7.3 Europe Mycobacterium Tuberculosis Market Size by Application
7.3.1 Europe Mycobacterium Tuberculosis Market Size by Application (2016-2021)
7.3.2 Europe Mycobacterium Tuberculosis Market Size by Application (2022-2027)
7.3.3 Europe Mycobacterium Tuberculosis Market Size by Application (2016-2027)
7.4 Europe Mycobacterium Tuberculosis Market Size by Country
7.4.1 Europe Mycobacterium Tuberculosis Market Size by Country (2016-2021)
7.4.2 Europe Mycobacterium Tuberculosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Mycobacterium Tuberculosis Market Size (2016-2027)
8.2 Asia-Pacific Mycobacterium Tuberculosis Market Size by Type
8.2.1 Asia-Pacific Mycobacterium Tuberculosis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Mycobacterium Tuberculosis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Mycobacterium Tuberculosis Market Size by Type (2016-2027)
8.3 Asia-Pacific Mycobacterium Tuberculosis Market Size by Application
8.3.1 Asia-Pacific Mycobacterium Tuberculosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Mycobacterium Tuberculosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Mycobacterium Tuberculosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Mycobacterium Tuberculosis Market Size by Region
8.4.1 Asia-Pacific Mycobacterium Tuberculosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Mycobacterium Tuberculosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Mycobacterium Tuberculosis Market Size (2016-2027)
9.2 Latin America Mycobacterium Tuberculosis Market Size by Type
9.2.1 Latin America Mycobacterium Tuberculosis Market Size by Type (2016-2021)
9.2.2 Latin America Mycobacterium Tuberculosis Market Size by Type (2022-2027)
9.2.3 Latin America Mycobacterium Tuberculosis Market Size by Type (2016-2027)
9.3 Latin America Mycobacterium Tuberculosis Market Size by Application
9.3.1 Latin America Mycobacterium Tuberculosis Market Size by Application (2016-2021)
9.3.2 Latin America Mycobacterium Tuberculosis Market Size by Application (2022-2027)
9.3.3 Latin America Mycobacterium Tuberculosis Market Size by Application (2016-2027)
9.4 Latin America Mycobacterium Tuberculosis Market Size by Country
9.4.1 Latin America Mycobacterium Tuberculosis Market Size by Country (2016-2021)
9.4.2 Latin America Mycobacterium Tuberculosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mycobacterium Tuberculosis Market Size (2016-2027)
10.2 Middle East & Africa Mycobacterium Tuberculosis Market Size by Type
10.2.1 Middle East & Africa Mycobacterium Tuberculosis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Mycobacterium Tuberculosis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Mycobacterium Tuberculosis Market Size by Type (2016-2027)
10.3 Middle East & Africa Mycobacterium Tuberculosis Market Size by Application
10.3.1 Middle East & Africa Mycobacterium Tuberculosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Mycobacterium Tuberculosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Mycobacterium Tuberculosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Mycobacterium Tuberculosis Market Size by Country
10.4.1 Middle East & Africa Mycobacterium Tuberculosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Mycobacterium Tuberculosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lupin
11.1.1 Lupin Company Details
11.1.2 Lupin Business Overview
11.1.3 Lupin Mycobacterium Tuberculosis Introduction
11.1.4 Lupin Revenue in Mycobacterium Tuberculosis Business (2016-2021)
11.1.5 Lupin Recent Development
11.2 Macleods Pharmaceuticals
11.2.1 Macleods Pharmaceuticals Company Details
11.2.2 Macleods Pharmaceuticals Business Overview
11.2.3 Macleods Pharmaceuticals Mycobacterium Tuberculosis Introduction
11.2.4 Macleods Pharmaceuticals Revenue in Mycobacterium Tuberculosis Business (2016-2021)
11.2.5 Macleods Pharmaceuticals Recent Development
11.3 Otsuka Pharmaceutical
11.3.1 Otsuka Pharmaceutical Company Details
11.3.2 Otsuka Pharmaceutical Business Overview
11.3.3 Otsuka Pharmaceutical Mycobacterium Tuberculosis Introduction
11.3.4 Otsuka Pharmaceutical Revenue in Mycobacterium Tuberculosis Business (2016-2021)
11.3.5 Otsuka Pharmaceutical Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Mycobacterium Tuberculosis Introduction
11.4.4 Johnson & Johnson Revenue in Mycobacterium Tuberculosis Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Mycobacterium Tuberculosis Introduction
11.5.4 Pfizer Revenue in Mycobacterium Tuberculosis Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Mycobacterium Tuberculosis Introduction
11.6.4 Novartis Revenue in Mycobacterium Tuberculosis Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Mycobacterium Tuberculosis Introduction
11.7.4 Abbott Revenue in Mycobacterium Tuberculosis Business (2016-2021)
11.7.5 Abbott Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Mycobacterium Tuberculosis Introduction
11.8.4 AstraZeneca Revenue in Mycobacterium Tuberculosis Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Mycobacterium Tuberculosis Introduction
11.9.4 Bayer Revenue in Mycobacterium Tuberculosis Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Mycobacterium Tuberculosis Introduction
11.10.4 Merck Revenue in Mycobacterium Tuberculosis Business (2016-2021)
11.10.5 Merck Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Mycobacterium Tuberculosis Introduction
11.11.4 Sanofi Revenue in Mycobacterium Tuberculosis Business (2016-2021)
11.11.5 Sanofi Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Details
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Mycobacterium Tuberculosis Introduction
11.12.4 Thermo Fisher Scientific Revenue in Mycobacterium Tuberculosis Business (2016-2021)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 Danaher
11.13.1 Danaher Company Details
11.13.2 Danaher Business Overview
11.13.3 Danaher Mycobacterium Tuberculosis Introduction
11.13.4 Danaher Revenue in Mycobacterium Tuberculosis Business (2016-2021)
11.13.5 Danaher Recent Development
11.14 Roche
11.14.1 Roche Company Details
11.14.2 Roche Business Overview
11.14.3 Roche Mycobacterium Tuberculosis Introduction
11.14.4 Roche Revenue in Mycobacterium Tuberculosis Business (2016-2021)
11.14.5 Roche Recent Development
11.15 Novartis
11.15.1 Novartis Company Details
11.15.2 Novartis Business Overview
11.15.3 Novartis Mycobacterium Tuberculosis Introduction
11.15.4 Novartis Revenue in Mycobacterium Tuberculosis Business (2016-2021)
11.15.5 Novartis Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Mycobacterium Tuberculosis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Real-time Inspection
Table 3. Key Players of Nucleic Acid Amplification Test
Table 4. Key Players of Skin Test for Tuberculosis
Table 5. Key Players of Other
Table 6. Global Mycobacterium Tuberculosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Mycobacterium Tuberculosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Mycobacterium Tuberculosis Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Mycobacterium Tuberculosis Market Share by Regions (2016-2021)
Table 10. Global Mycobacterium Tuberculosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Mycobacterium Tuberculosis Market Share by Regions (2022-2027)
Table 12. Mycobacterium Tuberculosis Market Trends
Table 13. Mycobacterium Tuberculosis Market Drivers
Table 14. Mycobacterium Tuberculosis Market Challenges
Table 15. Mycobacterium Tuberculosis Market Restraints
Table 16. Global Mycobacterium Tuberculosis Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Mycobacterium Tuberculosis Market Share by Players (2016-2021)
Table 18. Global Top Mycobacterium Tuberculosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mycobacterium Tuberculosis as of 2020)
Table 19. Ranking of Global Top Mycobacterium Tuberculosis Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Mycobacterium Tuberculosis Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Mycobacterium Tuberculosis Product Solution and Service
Table 23. Date of Enter into Mycobacterium Tuberculosis Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mycobacterium Tuberculosis Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Mycobacterium Tuberculosis Revenue Market Share by Type (2016-2021)
Table 27. Global Mycobacterium Tuberculosis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Mycobacterium Tuberculosis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Mycobacterium Tuberculosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Mycobacterium Tuberculosis Revenue Market Share by Application (2016-2021)
Table 31. Global Mycobacterium Tuberculosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Mycobacterium Tuberculosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Mycobacterium Tuberculosis Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Mycobacterium Tuberculosis Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Mycobacterium Tuberculosis Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Mycobacterium Tuberculosis Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Mycobacterium Tuberculosis Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Mycobacterium Tuberculosis Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Mycobacterium Tuberculosis Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Mycobacterium Tuberculosis Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Mycobacterium Tuberculosis Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Mycobacterium Tuberculosis Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Mycobacterium Tuberculosis Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Mycobacterium Tuberculosis Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Mycobacterium Tuberculosis Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Mycobacterium Tuberculosis Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Mycobacterium Tuberculosis Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Mycobacterium Tuberculosis Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Mycobacterium Tuberculosis Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Mycobacterium Tuberculosis Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Mycobacterium Tuberculosis Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Mycobacterium Tuberculosis Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Mycobacterium Tuberculosis Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Mycobacterium Tuberculosis Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Mycobacterium Tuberculosis Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Mycobacterium Tuberculosis Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Mycobacterium Tuberculosis Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Mycobacterium Tuberculosis Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Mycobacterium Tuberculosis Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Mycobacterium Tuberculosis Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Mycobacterium Tuberculosis Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Mycobacterium Tuberculosis Market Size by Country (2022-2027) & (US$ Million)
Table 63. Lupin Company Details
Table 64. Lupin Business Overview
Table 65. Lupin Mycobacterium Tuberculosis Product
Table 66. Lupin Revenue in Mycobacterium Tuberculosis Business (2016-2021) & (US$ Million)
Table 67. Lupin Recent Development
Table 68. Macleods Pharmaceuticals Company Details
Table 69. Macleods Pharmaceuticals Business Overview
Table 70. Macleods Pharmaceuticals Mycobacterium Tuberculosis Product
Table 71. Macleods Pharmaceuticals Revenue in Mycobacterium Tuberculosis Business (2016-2021) & (US$ Million)
Table 72. Macleods Pharmaceuticals Recent Development
Table 73. Otsuka Pharmaceutical Company Details
Table 74. Otsuka Pharmaceutical Business Overview
Table 75. Otsuka Pharmaceutical Mycobacterium Tuberculosis Product
Table 76. Otsuka Pharmaceutical Revenue in Mycobacterium Tuberculosis Business (2016-2021) & (US$ Million)
Table 77. Otsuka Pharmaceutical Recent Development
Table 78. Johnson & Johnson Company Details
Table 79. Johnson & Johnson Business Overview
Table 80. Johnson & Johnson Mycobacterium Tuberculosis Product
Table 81. Johnson & Johnson Revenue in Mycobacterium Tuberculosis Business (2016-2021) & (US$ Million)
Table 82. Johnson & Johnson Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Mycobacterium Tuberculosis Product
Table 86. Pfizer Revenue in Mycobacterium Tuberculosis Business (2016-2021) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Mycobacterium Tuberculosis Product
Table 91. Novartis Revenue in Mycobacterium Tuberculosis Business (2016-2021) & (US$ Million)
Table 92. Novartis Recent Development
Table 93. Abbott Company Details
Table 94. Abbott Business Overview
Table 95. Abbott Mycobacterium Tuberculosis Product
Table 96. Abbott Revenue in Mycobacterium Tuberculosis Business (2016-2021) & (US$ Million)
Table 97. Abbott Recent Development
Table 98. AstraZeneca Company Details
Table 99. AstraZeneca Business Overview
Table 100. AstraZeneca Revenue in Mycobacterium Tuberculosis Business (2016-2021) & (US$ Million)
Table 101. AstraZeneca Recent Development
Table 102. Bayer Company Details
Table 103. Bayer Business Overview
Table 104. Bayer Mycobacterium Tuberculosis Product
Table 105. Bayer Revenue in Mycobacterium Tuberculosis Business (2016-2021) & (US$ Million)
Table 106. Bayer Recent Development
Table 107. Merck Company Details
Table 108. Merck Business Overview
Table 109. Merck Mycobacterium Tuberculosis Product
Table 110. Merck Revenue in Mycobacterium Tuberculosis Business (2016-2021) & (US$ Million)
Table 111. Merck Recent Development
Table 112. Sanofi Company Details
Table 113. Sanofi Business Overview
Table 114. Sanofi Mycobacterium Tuberculosis Product
Table 115. Sanofi Revenue in Mycobacterium Tuberculosis Business (2016-2021) & (US$ Million)
Table 116. Sanofi Recent Development
Table 117. Thermo Fisher Scientific Company Details
Table 118. Thermo Fisher Scientific Business Overview
Table 119. Thermo Fisher Scientific Mycobacterium Tuberculosis Product
Table 120. Thermo Fisher Scientific Revenue in Mycobacterium Tuberculosis Business (2016-2021) & (US$ Million)
Table 121. Thermo Fisher Scientific Recent Development
Table 122. Danaher Company Details
Table 123. Danaher Business Overview
Table 124. Danaher Mycobacterium Tuberculosis Product
Table 125. Danaher Revenue in Mycobacterium Tuberculosis Business (2016-2021) & (US$ Million)
Table 126. Danaher Recent Development
Table 127. Roche Company Details
Table 128. Roche Business Overview
Table 129. Roche Mycobacterium Tuberculosis Product
Table 130. Roche Revenue in Mycobacterium Tuberculosis Business (2016-2021) & (US$ Million)
Table 131. Roche Recent Development
Table 132. Novartis Company Details
Table 133. Novartis Business Overview
Table 134. Novartis Mycobacterium Tuberculosis Product
Table 135. Novartis Revenue in Mycobacterium Tuberculosis Business (2016-2021) & (US$ Million)
Table 136. Novartis Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mycobacterium Tuberculosis Market Share by Type: 2020 VS 2027
Figure 2. Real-time Inspection Features
Figure 3. Nucleic Acid Amplification Test Features
Figure 4. Skin Test for Tuberculosis Features
Figure 5. Other Features
Figure 6. Global Mycobacterium Tuberculosis Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Specialist Clinic Case Studies
Figure 9. Diagnostic Laboratory Case Studies
Figure 10. Mycobacterium Tuberculosis Report Years Considered
Figure 11. Global Mycobacterium Tuberculosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Mycobacterium Tuberculosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Mycobacterium Tuberculosis Market Share by Regions: 2020 VS 2027
Figure 14. Global Mycobacterium Tuberculosis Market Share by Regions (2022-2027)
Figure 15. Global Mycobacterium Tuberculosis Market Share by Players in 2020
Figure 16. Global Top Mycobacterium Tuberculosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mycobacterium Tuberculosis as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Mycobacterium Tuberculosis Revenue in 2020
Figure 18. Global Mycobacterium Tuberculosis Revenue Market Share by Type (2016-2021)
Figure 19. Global Mycobacterium Tuberculosis Revenue Market Share by Type (2022-2027)
Figure 20. North America Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Mycobacterium Tuberculosis Market Share by Type (2016-2027)
Figure 22. North America Mycobacterium Tuberculosis Market Share by Application (2016-2027)
Figure 23. North America Mycobacterium Tuberculosis Market Share by Country (2016-2027)
Figure 24. United States Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Mycobacterium Tuberculosis Market Share by Type (2016-2027)
Figure 28. Europe Mycobacterium Tuberculosis Market Share by Application (2016-2027)
Figure 29. Europe Mycobacterium Tuberculosis Market Share by Country (2016-2027)
Figure 30. Germany Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Mycobacterium Tuberculosis Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Mycobacterium Tuberculosis Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Mycobacterium Tuberculosis Market Share by Region (2016-2027)
Figure 40. China Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Mycobacterium Tuberculosis Market Share by Type (2016-2027)
Figure 48. Latin America Mycobacterium Tuberculosis Market Share by Application (2016-2027)
Figure 49. Latin America Mycobacterium Tuberculosis Market Share by Country (2016-2027)
Figure 50. Mexico Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Mycobacterium Tuberculosis Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Mycobacterium Tuberculosis Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Mycobacterium Tuberculosis Market Share by Country (2016-2027)
Figure 56. Turkey Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Mycobacterium Tuberculosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Lupin Revenue Growth Rate in Mycobacterium Tuberculosis Business (2016-2021)
Figure 60. Macleods Pharmaceuticals Revenue Growth Rate in Mycobacterium Tuberculosis Business (2016-2021)
Figure 61. Otsuka Pharmaceutical Revenue Growth Rate in Mycobacterium Tuberculosis Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Mycobacterium Tuberculosis Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Mycobacterium Tuberculosis Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Mycobacterium Tuberculosis Business (2016-2021)
Figure 65. Abbott Revenue Growth Rate in Mycobacterium Tuberculosis Business (2016-2021)
Figure 66. AstraZeneca Revenue Growth Rate in Mycobacterium Tuberculosis Business (2016-2021)
Figure 67. Bayer Revenue Growth Rate in Mycobacterium Tuberculosis Business (2016-2021)
Figure 68. Merck Revenue Growth Rate in Mycobacterium Tuberculosis Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Mycobacterium Tuberculosis Business (2016-2021)
Figure 70. Thermo Fisher Scientific Revenue Growth Rate in Mycobacterium Tuberculosis Business (2016-2021)
Figure 71. Danaher Revenue Growth Rate in Mycobacterium Tuberculosis Business (2016-2021)
Figure 72. Roche Revenue Growth Rate in Mycobacterium Tuberculosis Business (2016-2021)
Figure 73. Novartis Revenue Growth Rate in Mycobacterium Tuberculosis Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界の結核診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tuberculosis Diagnostic Market The global Tuberculosis Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…- 世界の結核診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tuberculosis Diagnostic Market The global Tuberculosis Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…
- 世界の結核（TB）検出市場規模・現状・予測（2021年-2027年） Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease. Tuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The inc…
- 世界の潜在性結核感染症（LTBI）検査市場規模・現状・予測（2021年-2027年） The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc. Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc. Diagnosing and treating latent tuberculosis (T…
- 世界の結核診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tuberculosis Diagnosis and Treatment Market The global Tuberculosis Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…